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The  present  study  examined  the  role  of  some  imunogenetic  factors 
in  the  aetiology  of  pre-eclamptic  toxaemia. 
A  normal  pregnant  population  was  used  as  a  reference  population 
for  a  compatative  study  of  a  group  of  women  who  developed  severe 
pre-eclampsia/eclampsia. 
Rigid  diagnostic  criteria  were  employed  in  an  attelnpt  to  make  the 
clinical  diagnosis  as  unequivocal  as  possible.  This  made  the 
number  of  cases  available  for  study  quite  small,  but  was  necessary 
to  avoid  the  inclusion  of  such  mild  cases  of  pre-eclampsia  that 
the  diagnosis  must  be  seriously  in  doubt. 
The  genetic  marker  studies  revealed  no  linkage  association 
between  susceptibility  to  the  disease  and  any  particular  leucocyte 
antigen.  However,  there  appeared  to  be  a  higher  degree  of  HLA 
antigen  matching  between  the  pre-eclamptic  women  and  their  husbands 
than  between  the  normal  pregnant  women  and  their  husbands.  This 
has  some  similarity  to  the  Oxford  data  ( Redman  1975,  personal 
comunication )  which  shows  a  high  degree  of  parental  HLA 
homozygosity  in  severe  pre-eclampsia. 
This  matching  would  provide  for  less  histoincompatibility  between 
mother  and  fetus  and  thereby  the  fetus  would  fail  to  induce  a 
sufficiently  strong  maternal  immunological  recognition  of  itself, 
necessary  for  the  maintenance  of  normal  pregnancy. <, 
Such  an  hypothesis  is  supported  by  the  fail  ure  of  women   Iith 
severe  pre-eclampsia  in  this  study  to  develop  anti-HLA  cytotoxic 
an  ti bodi  es, 
The  immunological  studies  examined  both  the  cellular  and  humoral 
immune  response  of  the  mothers. 
The  PHA-induced  responsiveness  of  the  maternal  lymphocytes  was 
reduced  in  women  with  severe  pre-eclamptic  toxaemia.  While 
other  studies  have  shown  a  reduced  response  to  PHA  of  lymphocytes 
from  normal  pregnant  women,  this  seems  to  be  a  purely  serum  mediated 
inhibition  - the  intrinsic  function  of  the  lymphocytes  being  normal 
in  the  absence  of  maternal  serum.  The  results  of  the  present 
study  were  consistent  with  this  also.  However,  the  women  with 
severe  pre-eclampsia  had  a  greater  reduced  responsiveness  to  PHA 
and  the  suppressing  effect  of  maternal  serum  was  not  as  great  as 
in  normal  pregnancy, 
This  raises  two  possibilities.  Firstly,  that  the  lymphocytes  of 
women  with  severe  pre-eclampsia  are  depressed  by  a  non-serum 
factor.  Secondly,  that  there  is  a  reduced  ability  of  the  women 
with  severe  pre-eclampsia  to  produce  serum  blocking  or  inhibitory 
factors, 
The  specific  imunological  response  of  the  pre-eclamptic  mothers 
against  paternal  antigens  was  similar  to  that  of  normal  pregnant· o. 
women  and  little  or  no  serum  effect  was  noted.  Where  cord 
leucocyte  antigens  were  stimulatory  in  the  mixed  leucocyte  culture. 
however,  there  was  less  maternal  response  noted  in  pre-eclamptic 
pregnancies.  Again.  there  was  a  suggestion  that  the  inhibitory 
effect  of  maternal  serum  on  this  response  was  less  in  pre-eclamptic 
pregnancies  than  in  normal  pregnancies. 
The  role  of  the  fetus  in  the  development  of  pre-eclamptic  toxaemia 
has  generally  been  ignored.  The  fetus  is  imunologically  competent 
at  an  early  stage  of  its  development  (Jones  1976)  so  that  it  may 
well  take  an  active  role  in  its  survival  as  an  allograft.  Cord 
lymphocyte  responses  to  PHA  were  studied  and  noted  to  be  higher 
than  that  of  their  mothers,  but  similar  to  that  of  non-pregnant 
adults.  Cord  serum  had  no  effect  on  the  autologous  leucocyte 
response  to  PH/,. 
Cord  leucocyte  response  to  maternal  antigens  was  also  similar  in 
the  wo  groups  studied  and  the  effect  of  cord  serum  on  this  response 
was  interesting.  Where  the  pregnancy  was  normal,  there  was  no 
effect  but  in  severe  pre-eclamptic  pregnancies  the  serum  was 
immunosuppressive. 
The  difference  is  difficult  to  explain.  It  may  be  due  to  the 
fact  that  maternal  serum  seromucoid  is  elevated  in  severe  pre­
eclampsia  and  was  also  elevated  in  cord  serum  and  that  this  non­
specific  immunosuppressive  substance  may  be  responsible.  Such effect,  however,  was  not  noted  in  the  cord  responses  to  PHA  as 
would  be  expected. 
There  is  no  evidence,  from  this  study,  therefore,  that  the  fetus 
has  an  active  role  to  play  in  the  immunological  aetio1ogica1 
mechanisms  of  severe  pre-eclamptic  toxaemia. 
The  serum  imunoglobulins  were  also  examined.  IgA  levels  were 
similar  in  the  control  and  study  groups,  but  IgM  and  IgG  levels 
were  reduced  in  the  women  with  severe  pre-eclampsia.  While  IgG 
is  lost  in  large  quantities  in  the  urine,  this  is  not  so  of  IgM. 
Furthermore,  in  severe  pre-eclampsia  where  there  is  a  loss  of 
fluid  from  the  intravascular  space  so  that  the  blood  is  haemo­
concentrated  (Williams  1966)  these  low  levels  of  immunoglobulins 
are  even  more  significant. 
While  loss  of  IgG  in  the  urine  must  be  accepted  as  the  most  likely 
explanation,  an  immunological  explanation  is  possible  also 
( Benster  and  Wood  1970).  Accordingly,  the  following  possibility 
exists.  IgM  is  the  immunoglobulin  produced  in  the  initial 
immunological  response  with  IgG  produced  later  in  the  immunological 
response  ( Rowe  1975).  The  initial  challenge  of  a  first  pregnancy 
may,  therefore,  induce  first  IgM  and  then  IgG  later.  If  this 
immunological  response  is  inadequate,  then  the  production  of  both 
these  immunoglobulins  would  be  reduced. It  is  possible.  then,  that  the  lower  levels  of  IgM  and  JgG 
observed  in  the  women  with  severe  pre-eclampsia  may  be  compatible 
with  the  overall  hypothesis  that  women  who  develop  severe  pre­
eclampsia  are  imunologically  hypo-responsive  to  the  fetal  antigenic 
challenge.  This  is  further  supported  by  the  findings  of  this 
study  in  relation  to  the  specific  anti-HLA  antibody  formation. 
Women  with  severe  pre-eclampsia  failed  to  produce  detectable 
anti-HLA  antibodies,  unlike  the  women  whose  pregnancies  were  normal. 
The  non-specific  serum  factor  studied  was  serum  seromucoid.  This 
was  significantly  elevated  in  the  women  with  severe  pre-eclampsia 
and  confirms  other  studies.  It  has  ueen  suggested  that  the 
production  of  seromucoid  is  a  compensation  by  the  maternal  organism 
for  her  inability  to  mount  an  adequate  specific  immunological 
response  ( Good  1975). 
That  the  maternal  host  with  severe  pre-eclampsia  is  unable  to 
mount  an  adequate  i nunological  response  is  further  supported  by 
the  lower  response  to  phytohaemagglutinin  and  the  reduced 
blocking  activity  of  matemal  serum. 
The  results  of  this  study,  therefore,  suggest  that  women  who  develop 
severe  pre-eclampsia  make  an  inadequate  immunological  adaptation  to 
the  antigenic  challenge  of their  pregnancy.  The  possible  mechanism 
proposed  is  that  the  recognition  phase  of  blocking  antibody  prod­
uction  is  impaired.  This  results  in  "inadequate  enhancing antibodies  for  the  maintenance  of  normal  pregnancy  so  that  pre­
eclamptic  toxamia  develops. 4; ';  >, 
LYI{'f?> ;   \"\  "  ,C ,"/ 
'j 
 'I"  /,j 
.: sli:i ..\  .. ·,7 
,    
;',7 , .; -,: 
I 
 "  ) -    . 
... 
THE  ROLE  OF  It MUNOGENETI C  FACTORS  n  THE 
AETIOLOGY 	 OF  PRE-ECLAMPTIC  TOXAE HA  OF 
HU lAN  PREGNANCY 
Vo lume  JJ 
by 
JILLIMI  ANN  NEED,   1.B.,  B.S.  ( Adelaide) 
Being  a  Thesis 
presen  ted  for  the 
Degree  of 
DOCTOR  OF  MEDICINE 
at  the 

University  of  Adelaide 

Department  of  Obstetrics  and  Gynaecology, 
University  of  Leeds,  England. 





SECTION  V 
CONTENTS  VOLUME  II 
_......  _  ..  .  ,-
APPENDIX  A  {'lETHO OOLOGY  OF  LEUCOCYTE  CULTURES 
SECTION  VI  - RESULTS 
APPE  01 X  B  NON-SPECIFIC  CELLULAR  IMMUNE  RESPONSE 
APPENDIX  C  SPEC! FI C  CELLULAR  IMr UNE  RESPONSE  - 58 
 1I XED  LEUCOCYTE  CULTURES 
r PPENDIX  D  BLOOD  GROUP  ANTI GENS  - ABO  and  RHESUS  73 
APPENDIX  E  HUrW1  LEUCOCYTE  ANTI  GEN  TYPES  77 
APPENDIX  F  ANTI  HL-A  ANTIBODIES  -
,.  CYTOTOXIC 
CROSS- 1A TCHES 
APPENDIX  G  S  ERU l  rr·l lUNOGLOBULI  NS 
APPE:W I  X  H  SERUM  SEROHUCOI  D  113 
SECTION  VII  BIBLIOGRAPHY  - VOLUME  I I  120 
, 
94 